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Abstract
We propose two semiparametric estimators of the dose-response function
based on spline techniques. Under uncounfoundedness, the generalized
propensity score can be used to estimate dose-response functions (DRF) and
marginal treatment effect functions. In many observational studies treatment
may not be binary or categorical. In such cases, one may be interested in es-
timating the dose-response function in a setting with a continuous treatment.
We evaluate the performance of the proposed estimators using Monte Carlo
simulation methods. The simulation results suggested that the estimated DRF
is robust to the speciﬁc semiparametric estimator used, while the parametric
estimates of the DRF were sensitive to model mis-speciﬁcation. We apply
our approach to the problem of evaluating the effect on innovation sales of
Research and Development (R&D) ﬁnancial aids received by Luxembourgish
ﬁrms in 2004 and 2005.
Keywords: Continuous treatment; Dose-response function; Generalized
propensity score; Non-parametric methods; R&D investment
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Nonexperimental methods are important in economics and many other ﬁelds to evaluate the
effects of policies or interventions in the absence of an experiment. In many applications
the units under study may receive different levels of the treatment, in which case estimation
of dose-response functions is of interest. In order to adjust for systematic differences in back-
ground characteristics occurring between groups with different levels of the treatment variable,
a key identifying assumption is that selection into levels of the treatment is random conditional
on a set of observable pre-treatment variables (unconfoundedness). Propensity score methods
are usually employed for the estimation of causal effects under unconfoundedness in a binary
treatment setting, where the propensity score is deﬁned as the probability of receiving treat-
ment conditional on the observable pre-treatment variables (Rosenbaum and Rubin, 1983).
Over the last years, several extensions of propensity score-based methods have been devel-
oped. Imbens (2000) and Lechner (2001) extended propensity score matching to handle a
categorical treatment variable. For an ordinal treatment variable, Joffe and Rosenbaum (1999)
and Lu et al. (2001) developed and applied a method based on a scalar “balancing score”,
which is a variable that balances pre-treatment variables among different comparison groups.
Hirano and Imbens (2004) introduced the concept of Generalized Propensity Score (GPS) and
extended the results in Rosenbaum and Rubin (1983) to the case of a continuous treatment.
The GPS is deﬁned as the conditional density of the treatment level given the observed covari-
ates. Under unconfoundedness, GPS methods can be used to estimate dose-response functions
(DRF) and marginal treatment effect functions. Imai and Van Dyk (2004) introduced a similar
concept to the GPS, the “propensity function”, allowing for arbitrary treatment regimes.
Hirano and Imbens (2004) discuss estimation of dose-response functions based on employ-
ing the GPS as a balancing score, and implement their approach in a parametric framework.
Flores et al. (2011) use the GPS within a weighting and introduce a semiparametric estimator
of the DRF based on kernel techniques. In this paper we propose two new semiparametric esti-
mators of the dose-response function based on spline methods and compare them with both the
parametric method in Hirano and Imbens (2004) and the semiparametric estimator proposed
by Flores et al. (2011).
The estimation strategy we follow for estimation of the DRF, which is based on the ap-
1proach in Hirano and Imbens (2004), consists of the following two steps. The ﬁrst step in-
volves a parametric but ﬂexible estimation of the GPS based on generalized linear models; and
the second step estimates the DRF adjusting for the GPS using regression techniques. Most
of the existing studies use a full parametric approach in the second step, employing a polyno-
mial approximation for the conditional expectation of the outcome variable given the treatment
variable and the estimated GPS (e.g., Hirano and Imbens, 2004; Kluve et al., 2007; Mattei and
Bia, 2008). The estimators we propose in this paper employ semiparametric techniques in this
second step using either a cubic spline estimator or a penalized cubic spline estimator.
We compare these estimators with the inverse-weighting (IW) estimator proposed by Flo-
res et al. (2011), using Monte-Carlo simulation. In this exercise we consider different sample
sizes and dose-response functions. To the best of our knowledge, this is the ﬁrst simulation
study comparing different GPS-based estimators of the DRF.
AlltheGPS-basedestimatorsoftheDRFconsideredinthispaperwillbealsoappliedtothe
problem of evaluating the effect of Research and Development (R&D) ﬁnancial aids received
by Luxembourgish ﬁrms in 2004 and 2005 on innovation sales in 2006, where innovation
sales are deﬁned as sales linked to innovation processes set up between 2004 and 2005. A
distinct feature of our empirical study is that we are interested in assessing the impact of the
intensity of R&D subsidies, by using the amount of policy exposure as a continuous variable.
We would expect that ﬁrms receiving different amounts of contribution will differ in their
market outcomes. For this reason, we argue that it is important to go beyond estimation of
the causal effects of public policies employing a binary discrete intervention (to be exposed or
not to a policy), and instead to estimate dose-response functions and marginal treatment effect
functions of receiving different levels of R&D ﬁnancial aid, which also allow us to uncover
heterogeneities in the effects of different contribution levels.
The rest of the paper is organized as follows: in Section 2 we ﬁrst brieﬂy review the
parametric approach in Hirano and Imbens (2004) and the semiparametric IW estimator in
Flores et al. (2011). Then we introduce spline-based estimators of the dose-response function.
In this section we also compare each alternative approach by simulation. Section 3 describes
the data set used in our empirical application and shows the evaluation results for the effects
of R&D contributions to Luxembourgish ﬁrms on innovations sales. Section 4 concludes and
discusses directions for future research.
22 Estimation Strategy
2.1 Reference Framework
Using the potential outcome approach to causal inference (Rubin, 1974, 1978), we estimate a
continuous dose-response function that relates each value of the dose, i.e., incentive level, to
the post-treatment level of ﬁrms’ innovation sales. Formally, consider a set of N enterprises,
and denote each of them by subscript i: i = 1;:::;N. For each ﬁrm i, we observe a vector of
pre-treatment variables, Xi, the received incentive amount, Ti, and the value of the outcome
variable associated with this treatment level, Yi = Yi(Ti). In order to formally describe the
econometric framework we adopt, extra notation is required. Let Yi(t) denote a random vari-
able that maps a particular potential treatment, t, t 2 T  R, to a potential outcome. We
are interested in the average dose-response function, (t) = E[Yi(t)]. Following Hirano and
Imbens (HI) (2004), we assume that fYi(t)gt2T , Ti, and Xi are deﬁned on a common probabil-
ity space, that Ti is continuously distributed with respect to Lebesgue measure on T , and that
Yi = Yi(Ti) is a well deﬁned random variable. Throughout this article, we make the Stable
Unit Treatment Value Assumption (SUTVA, Rubin 1980, 1990), which implies that there is
no interference between ﬁrms and that each level of the treatment deﬁnes a single outcome for
each ﬁrm.
Our key identifying assumption in estimating the DRF is the weak unconfoundedness as-
sumption, generalized to case of continuous treatment variables by Hirano and Imbens (2004).
This assumption requires that the treatment assignment mechanism is independent of each po-
tential outcome conditional on the pre-treatment variables: Yi(t) ? TijXi for all t 2 T . For
instance, in our empirical study, this assumption implies that all variables that affect both the
outcome (innovation sales in 2006) and the likelihood of receiving a given amount of ﬁnancial
aid are observed, and that all the others are perfectly collinear with the observed ones.
Given unconfoundedness, we can apply the methods based on the GPS with continuous
treatments introduced by Hirano and Imbens (2004). The GPS is deﬁned as the conditional
density of the treatment given the observed covariates: r(t;x) = fTjX(tjx). Let Ri = r(Ti;Xi)
denote the conditional density at the treatment level actually received. The GPS is a balancing
score (e.g., Rosenbaum and Rubin, 1983), that is, within strata with the same value of r(t;x),
the probability that T = t does not depend on the value of X. In combination with the weak
3unconfoundedness assumption, this balancing property implies that for every t 2 T
fT (tjr(t;Xi);Yi(t)) = fT (tjr(t;Xi)):
As a result, the GPS can be used to eliminate any bias associated with differences in the
covariates among groups receiving different levels of the treatment. Formally, Hirano and
Imbens (2004) show that if the assignment to the treatment is weakly unconfounded given
pre-treatment variables Xi, then
(t;r) = E [Yi(t)jr(t;Xi) = r] = E [YijTi = t;Ri = r]
and
(t) = E [(t;r(t;Xi))]:
This result suggests that the dose-response function at t can be estimated using a partial
mean approach (Newey, 1994), that is, averaging the regression function (t;r(t;Xi)) over
the covariates Xi, while holding ﬁxed the treatment level t. Hence, the dose-response function
can be estimated using the GPS by the following steps. In the ﬁrst stage, we estimate the GPS
using a parametric but ﬂexible approach. Let b Ri denote the estimated GPS at the treatment
actually received, and let b Rt
i = b r(t;Xi) denote the estimated score at a speciﬁc treatment
level, t. In the second stage, we estimate the dose-response function using the estimated GPS
by following two steps. The ﬁrst step involves estimating the conditional expectation of Yi
given Ti and the estimated GPS b Ri, E(YijTi;c Ri). The second step involves averaging this
conditional expectation over b Rt
i to get the value of the dose-response function at t. Intuitively,
we need to integrate over b Rt
i = b r(t;Xi) in the second step because the potential outcomes at t
are independent of T conditional on Rt
i.
In this paper, we apply both parametric and nonparametric partial mean estimators. Fol-
lowing HI, we implement a partial mean approach by assuming a (ﬂexible) parametric form
for the regression function of Yi on Ti and b Ri. Speciﬁcally,
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.
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ically, g(t; b Rt





> > > > > > <
> > > > > > :
g1(t; b Rt
i) if k1  t < k2
g2(t; b Rt
i) if k2  t < k3
. . .
gp 1(t; b Rt
i) if kp 1  t < kp
where gj is a pre-ﬁxed degree polynomial and k1 < ::: < kp are p distinct knots in the support
of T, T . The piecewise function g must interpolate all knots and be twice continuously dif-
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In order to address overﬁtting problems, we also propose an estimator based on the penal-









The parameter  introduces a penalty for lack of smoothness. More speciﬁcally, if  is
small, the solution will be a spline, which almost interpolates the data points; conversely, if
 = 1 then we get an OLS ﬁt to the data. Penalized splines can be formalized in several ways;
here we use a mixed model approach. In this paper, we focus on a penalized cubic spline.
5In addition to the partial-mean based estimators above, we also consider the semiparamet-
ric Inverse-Weighting (IW) estimator based on the kernel method proposed by Flores et al.
(2011). Instead of using the GPS as a balancing score, this approach uses the GPS to weight
the observations in order to adjust for differences in the pre-treatment variables across groups
receiving different treatment levels. We implement the IW estimator by choosing a global
bandwidth based on the procedure proposed by Fan and Gijbels (1996). The unknown terms
appearing in the optimal global bandwidth is estimated by employing a global polynomial of
order p plus 3, where p is the order of the local polynomial ﬁtted.
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2.2 Monte Carlo Simulations: HI, IW and Spline Estimator
In this section we aim at comparing the alternative GPS-based estimation approaches of the
DRF by simulation. We generate 100 samples of size n = 50 and n = 500 respectively,
where the outcome (innovation sales in 2006) and the treatment (public R&D contributions)
are randomly generated from reference populations. Speciﬁcally, we consider two different
“true” unit-level dose-response functions; non linear and linear in the treatment parameter,
respectively:


















where ei is the error term normally distributed: ei  N(0;0:72), and the r(t;Xi) is derived
assuming the normality of the treatment variable (or of its transformation) conditional on the
pre-treatment covariates. In our simulations, we assume that the logarithm of the treatment









As we can clearly see from Figure 1 (left panel), all techniques work very well when
applied to estimating the linear dose-response function. Therefore we mainly focus on the non-
linear case (Figure 1, right panel). Our simulation results show that both the IW estimator and
the Spline estimators ﬁt “reasonably well” the true non linear mean dose-response, although
both the estimators underﬁt the true values for central treatment levels and overﬁt the tails of
the true dose-response distribution.
Figure 3 shows the biases, the mean square errors and the coverage of nominal 95% conﬁ-
dence intervals, which are deﬁned as the percentage of Monte-Carlo replications for which the
corresponding nominal 95% conﬁdence intervals include the true value of the dose-response
function. The IW kernel, Spline and Penalized Spline estimators have coverage rates of 95%
for most of the treatment values considered in the simulation. Concerning the parametric ap-
proach, the dose-response function is barely misspeciﬁed and the coverage is poor. Moreover,
the IW and Spline estimators have lower bias and lower mean square error than the parametric-
based estimator.
Needless to say the performance of all the techniques improves substantially considering a
sample of bigger size (n = 500). Figures 4 and 5 clearly show the excellent performance for
the IW estimator and the Spline estimators. They ﬁt the non linear true mean dose-response
very well; biases reduce signiﬁcantly and mean square errors are very close to 0, coverage rates
are high, in particular for treatment levels greater than 150,000 euro, and conﬁdence intervals
are very thin (see Figure 6). Note also that the highest bias and mean square as well as the
lowest coverage rate for the true mean value of the dose-response function are again found in
the parametric approach.
7Figure 1: Linear and non linear Dose Response Function by HI, Kernel, Spline and Penalized
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Figure 2: 95% conﬁdence bands for the non linear Dose-Response Function by HI, Kernel,
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8Figure3: Bias, MeanSquareError(MSE)andCoverageRatesforthenonlineardose-response
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Figure 4: Linear and non linear Dose Response Function by HI, Kernel, Spline and Penalized
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9Figure 5: 95% conﬁdence bands for the non linear Dose-Response Function by HI, Kernel,
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Figure6: Bias, MeanSquareError(MSE)andCoverageRatesforthenonlineardose-response








































































































































































































































































































































Firms’ innovation policies are an important feature to support local enterprises. Technological
investments are considered an efﬁcient strategy to guarantee competitiveness both at the ﬁrm-
level and for the economy as a whole (Jones, 2005; Aghion and Howitt, 2005). Research &
Development (R&D) investments fall in the class of interventions expected to set up techno-
logical progress and facilitate growth in the long-run (David et al., 2000; Cerulli, 2010). Many
recent studies deal with public policies designed to encourage ﬁrms’ investment in innovative
activities, including public measures aimed at fostering innovation by strengthening and ex-
tending patent rights (Gallini, 2002) and R&D investments (David et al., 2000; Falk, 2004;
Almus and Czarnitzki, 2003).
Note that, despite a favourable economic framework, the Luxembourgish national R&D
expenditures are lower than the European average. More than 80% of national R&D measures
are undertaken by private ﬁrms (Nguyen, 2007) and only in the last years they have been con-
sidered as national priority, leading policy makers to invest more in innovation. Due to this
‘peculiarity’, there are speciﬁc sections in the Community Innovation Survey (CIS) designed
to distinguish between internal and external R&D fundings. The formers are investments on
research and innovation directly provided by the ﬁrm itself or by a group of two or more
enterprises under common ownership1; the latters are external funds supplied by the Luxem-
bourgish Ministry of Economy. This study focuses on this last aspect, analysing the impact of
public ﬁnancial aids on innovation sales in 2006.
3.1 Data: The Community Innovation Survey 2004-2006
The Community Innovation Survey (CIS) is carried out by “The Central Service for Statistics
and Economic Studies” (STATEC) along with “The Centre for Population, Poverty and Public
Policy Studies” of Luxembourg (CEPS/INSTEAD), and it collects information about product,
process and marketing innovation for ﬁrms in Luxembourg. Most questions cover new or
improved goods or services, the implementation of new or improved processes, and logistic
1Other sources can be also represented by economic supports from partner enterprises of a speciﬁc R&D
project established in (or outside) Luxembourg or from European framework programmes on R&D.
11and distribution methods.
In this section we aim at evaluating the impact of R&D contributions provided to the Lux-
embourgish ﬁrms in 2004 and 2005 by the Luxembourgish Ministry of Economy, using a panel
dataset obtained by matching ﬁrms from the fourth and sixth Community Innovation Survey
(CIS 2004 and CIS 2006)2. The outcome variable of interest is the amount of innovation sales
in 2006, deﬁned as sales linked to innovation processes set up between 2004 and 2005. No at-
trition problem occurred in assembling the CIS 2004 and 2006 samples: medium- and big-size
ﬁrms were interviewed in both surveys. Our sample includes all the 22 CIS ﬁrms receiving
R&D contributions. From this sample of ﬁrms we discarded 4 ﬁrms, which received very high
economic supports from the Ministry between 2004 and 2005, focusing on ﬁrms receiving
between 3,000 and 356,000 euro.
The observed pre-treatment characteristics include a dummy variable for the ﬁrms’ size
(equal to 1 for ﬁrms having more than 249 employees and 0 otherwise); a dummy variable for
the sector (equal to 1 for ﬁrms operating in technological-manufacturing sector and 0 other-
wise); the employment level in 2004; the percentage of employees with higher education; a
dummy variable for the ﬁrms’ domicile (equal to 1 for ﬁrms having domicile in Luxembourg
and 0 otherwise); the amount of innovation sales in 2004; the total sales amount in 2004; a
dummy variable for the type of private ﬁnancial aid received in 2004 (equal to 1 if the ﬁrm re-
ceives in-house R&D contributions or R&D funds from a partner ﬁrm, 0 otherwise); a dummy
variable for the reference market (equal to 1 if a ﬁrm is active in the international market and
0 otherwise); the amount of in-house R&D investment in 2004 and the level of public R&D
contributions received in 2004. Some of these pre-treatment variables suffer from missing
data: only 12 out 22 ﬁrms provide complete information. We address this issue using Multiple
Imputation methods under the missing at random assumption. We assume that unconfound-
edness holds conditional on all the pre-treatment variables listed in Section 3.1, arguing that
these variables are good proxies of factors that might affect the intensity of the ﬁnancial aid
(Rubin, 2008).
Note that these data provide a unique opportunity to estimate the dose-response function
of Luxembourgish enterprises to learn whether there exist differences in the returns to amount
2We are particularly grateful to Vincent Dautel, who run all the programs we developed and provided, as we
did not have direct access to the data.
12of ﬁnancial aids. In addition, this analysis may inform policy makers about how to improve
the efﬁcacy of ﬁnancial contributions provided to ﬁrms in Luxembourg.
Although many aspects of the effect of R&D subsidies have been investigated, there is a
lack of empirical evidence on the analysis of research incentives provided by the Luxembourg
Goverment. In addition, to the best of our knowledge, the existing studies on the impact eval-
uation of R&D measures in Luxembourg focus on the effect of receiving versus not receiving
R&D subsidies (e.g., Nguyen, 2007; Czarnitzki and Lopes Bento, 2010; Dautel and Walther,
2010). Using data from CIS 2004, Nguyen (2007) ﬁnds that there are strong differences in
the public fundings accross sectors and ﬁrms’ sizes. Dautel and Walther (2010) analyse the
local determinants of innovation in the Luxembourg Metropolitan Region, using the CIS 2006
innovation survey. They show space matters according to both spatial units and accessibility
in the infra-regional context of Luxembourg. Czarnitzki and Lopes Bento (2010) focus on the
effect of public incentives on internal R&D investment and total innovation intensity at a cross-
country comparative level, ﬁnding that on average ﬁrms would have invested signiﬁcantly less
if they would not have received subsidies and that almost all the governments would beneﬁt
from an extension of their economic support policies to not ﬁnanced ﬁrms.
3.2 Estimation Results
In our empirical study we focus on the impact evaluation of R&D ﬁnancial aids (Euro per
1000) provided to Luxembourgish enterprises in 2004 and 2005. To be effective, innovation
sales estimation should involve ﬁrms balanced with respect to their characteristics. The extent
to which this has been achieved can be explored by comparing balance in the covariates among
two groups before and after adjusting for the GPS.
We ﬁrst estimate the GPS, that is, the conditional distribution of the logarithm of the
amount of R&D contribution given the covariates, and check its balancing property. Adjusting
for the GPS seems to improve the balance, especially when the unadjusted differences are high
(See Table 1). Next, we estimate the dose-response function using the estimators previously
described. The results are shown in Figures 7 and 8. Figure 7 shows the DRF estimates of
the amount of R&D contribution on innovation sales: although all the estimators suggest that
there exists a positive relationship between innovation sales and amount of R&D contribution,
the IW Kernel and Spline estimators show a non-linear relationship, while the parametric es-
13timator reveals a linear and smooth shape of the dose-response function. In Figure 8, each
estimate of the DRF derivative is accompanied by 95% conﬁdence bands obtained using boot-
strap methods that account for all estimation steps, including the estimation of the GPS. As we
can see in Figure 8, the IW Kernel and Spline estimators suggest that ﬁnancial aid has a posi-
tive and highly signiﬁcant marginal effect on innovation sales for treatment levels of medium
or high intensity. The HI technique reveals linear and positive (although negligible) effects of
ﬁnancial aid on innovation sales. The IW and PEN-Spline estimates are very similar to each
other, whereas there are important differences between these semiparametric DRF estimates
and the HI parametric estimates, especially in terms of standard errors signiﬁcantly higher in
the HI model than in the nonparametric methods (see Table 2). Table 3 highlights this as-
pect showing very high standardized mean differences for the HI versus IW and PEN-Spline
techniques, but also for the Cubic Spline versus IW and PEN-Spline estimators. Most of the
standardized mean differences between the Kernel and PEN-Spline models are lower than 3.5.
Table 1: Mean differences among covariates a
Pre-treatment variable Unadjusted Adjusted for the GPS
[0, 40][40, 356] [0, 40][40, 356]
Sector 2004 0.333 -0.333 0.243 -0.267
[0.236] [0.236] [0.248] [0.249]
Size 2004 -0.333 0.333 -0.283 0.298
[0.229] [0.229] [0.241] [0.243]
International market 2004 0.000 0.000 -0.010 -0.089
[0.157] [0.157] [0.170] [0.186]
Domicile 2004 0.111 -0.111 0.101 -0.089
[0.184] [0.184] [0.195] [0.192]
In-house or group investment 2004 -0.222 0.222 -0.132 0.227
[0.242] [0.242] [0.255] [0.252]
Employees with high education 2004 0.161 -0.161 0.163 -0.162
[0.080] [0.080] [0.096] [0.082]
Log Innovation Sale 2004 0.483 -0.483 0.923 -0.034
[3.145] [3.145] [2.780] [3.171]
Log turnover 2004 -1.159 1.159 -0.781 1.247
[0.653] [0.653] [0.654] [0.699]
Log employment 2004 -1.098 1.098 -0.846 1.140
[0.510] [0.510] [0.508] [0.556]
Log public R&D contributions 2004 23.355 -23.355 0.285 -24.118
[37.245] [37.245] [3.047] [33.453]
Log private R&D contributions 2004 2.195 -2.195 -3.410 -3.224
[11.699] [11.699] [7.241] [10.617]
a(Standard erros in brackets)
14Table 2: Dose response estimates by modela
Treatment valuesb Parametric Kernel Splines PENSplines
8 15.521 14.875 15.445 14.845
[0.231] [0.195] [0.159] [0.069]
16 15.521 14.875 15.445 14.845
[0.133] [0.147] [0.198] [0.087]
24 15.521 14.875 15.445 14.845
[0.068] [0.156] [0.296] [0.300]
32 15.521 14.875 15.445 14.845
[0.053] [0.215] [0.428] [0.321]
40 15.521 14.875 15.445 14.845
[0.067] [0.446] [0.510] [0.238]
88 15.521 14.875 15.445 14.845
[0.262] [0.393] [0.064] [0.025]
104 15.521 14.875 15.445 14.845
[0.327] [0.383] [0.151] [0.153]
128 15.521 14.875 15.445 14.845
[0.430] [0.195] [0.416] [0.334]
192 15.521 14.875 15.445 14.845
[0.789] [0.162] [0.240] [0.037]
320 15.521 14.875 15.445 14.845
[2.099] [0.216] [0.567] [0.410]
344 15.521 14.875 15.445 14.845
[2.440] [0.063] [0.768] [0.406]
352 15.521 14.875 15.445 14.845
[2.561] [0.141] [0.837] [0.378]
a(Standard errors in brackets)
b(We reported a grid of treatment values considered in the empirical study)
Table 3: Standardized Mean Differences by model
Treatmenta HI vs IW HI vs Sp HI vs PEN IW vs Sp IW vs PEN Sp vs PEN
8 -0.400 -2.365 -1.700 -2.154 -1.395 1.461
16 0.974 2.891 4.926 2.011 3.436 0.418
24 4.015 4.261 5.257 1.831 2.762 0.760
32 5.800 1.224 3.098 -1.576 -0.713 0.896
40 4.061 -0.799 0.218 -3.311 -3.417 0.826
88 0.549 1.187 0.140 0.152 -0.564 -4.103
104 0.248 -0.970 0.552 -1.153 0.180 2.548
128 0.397 -3.034 -0.316 -4.354 -0.928 3.077
192 -1.804 -0.262 -1.955 4.266 -0.547 -5.464
320 1.369 0.382 1.168 -3.393 -0.844 2.382
344 0.542 0.164 0.898 -1.172 2.189 2.075
352 0.213 0.104 0.706 -0.314 3.177 1.686
aEuro per 1000

























Figure 8: Evaluation of the amount of public R&D aids on the logarithm of Innovation sales:
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164 Conclusion
Severe model misspeciﬁcation can lead to biased results. We address this issue proposing
two new semiparametric estimators of the DRF based on spline methods, in the framework of
continuous treatment regimes.
We conduct simulation exercises to investigate the performance of our techniques. We can
argue that we get reliable estimates given the high performance of both the IW kernel and
Spline estimators in the simulation. The coverage rates are often very high (95% for almost
all treatment values), and both mean square errors and bias levels are very low if compared
with the parametric technique. This is also more important if considering very small sample
sizes. These results highlight the potential advantages of using nonparametric techniques,
which allow one to avoid mis-speciﬁcation problems.
In our application, we also provide empirical evidence on the impact of public R&D con-
tributions on Luxembourgish ﬁrms’ performances. We address these issues focusing on the
causal effect of receiving different amounts of ﬁnancial aid on innovation sales. We argue
that estimating marginal effects of the intensity of economic supports provide more informa-
tion regarding the effectiveness of the public interventions and might help policy makers in
an effective allocation of public resources. Speciﬁcally, the nonparametric estimators show a
non-linear relationship between innovation sales and amount of R&D contribution.
There are many directions for future research. The ﬁrst is to extend this study by imple-
menting a nonparametric speciﬁcation of the GPS. Second, it could be of considerable interest
to check the presence of unobservable heterogeneity sources and analyze the robustness of our
results with respect to the underlying identifying assumptions, through appropriate sensitivity
analyses.
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